DOCSLIB.ORG

Venous Symposium: Overview

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Venous Symposium: Overview 5/30/2017 1 5/30/2017 VENOUS SYMPOSIUM: OVERVIEW Robert W. Vorhies, M.D., F.A.C.S. Vascular and Endovascular Surgery Endovenous Therapy and Vein Aesthetics Ferrell-Duncan Clinic, Cox Health Systems WHY DO WE CARE? • Epidemiology • Disability • Historical experience • Opportunity 2 5/30/2017 EPIDEMIOLOGY QUESTION #1 Which state has nearly the same population as all the people in the US with venous disease? • A. New York • B. Florida • C. California • D. Missouri EPIDEMIOLOGY QUESTION #1 Which state has nearly the population as all the people in the US with venous disease? • A. New York • B. Florida • C. California • More than 11 million men and 22 million women between the ages of 40 and 80 years in the United States have varicose veins. • Prevalence of 20% (range, 21.8%-29.4%) • D. Missouri Peter Gloviczki, Anthony J. Comerota, Michael C. Dalsing, Bo G. Eklof, David L. Gillespie, Monika L. Gloviczki, Joann M. Lohr, Robert B. McLafferty, Mark H. Meissner, M. Hassan Murad, Frank T. Padberg, Peter J. Pappas, Marc A. Passman Joseph D. Raffetto, Michael A. Vasquez, and Thomas W. Wakefield. “The care of patients with varicose veins and associated chronic venous diseases: Clinical practice guidelines of the Society for Vascular Surgery and the American Venous Forum.” J Vasc Surg . 2011;53:2S-48S. 3 5/30/2017 EPIDEMIOLOGY QUESTION #2 • Which mid western metropolitan area has about the same number of people as those with severe chronic venous insufficiency including ulcers and skin changes? • A. Minneapolis • B. Chicago • C. St. Louis • D. Kansas City. EPIDEMIOLOGY QUESTION #2 • Which mid western city has about the same number of people as those with severe chronic venous insufficiency including ulcers and skin changes? • A. Minneapolis • B. Chicago • C. St. Louis •D. Kansas City • About 2 million adults have advanced chronic venous disease (CVD) with skin changes or ulcers. • Venous edema, skin changes or venous ulcerations: about 5% (range, 3.6%-8.6%) • Active venous ulcers up to 0.5%, and 0.6% to 1.4% have healed ulcers. Peter Gloviczki, Anthony J. Comerota, Michael C. Dalsing, Bo G. Eklof, David L. Gillespie, Monika L. Gloviczki, Joann M. Lohr, Robert B. McLafferty, Mark H. Meissner, M. Hassan Murad, Frank T. Padberg, Peter J. Pappas, Marc A. Passman Joseph D. Raffetto, Michael A. Vasquez, and Thomas W. Wakefield. “The care of patients with varicose veins and associated chronic venous diseases: Clinical practice guidelines of the Society for Vascular Surgery and the American Venous Forum.” J Vasc Surg . 2011;53:2S-48S. 4 5/30/2017 EPIDEMIOLOGY QUESTION #3 • Which Ozarks area community has about the same number of people as those with newly diagnosed venous ulcers? • A. Springfield • B. Nixa • C. Harrison • D. Joplin QUESTION #3 • Which Ozarks area community has about the same number of people as those with newly diagnosed venous ulcers? • A. Springfield • B. Nixa • In the United States each year, at least 20,556 patients receive a new diagnosis of venous ulcers. • C. Harrison • D. Joplin Peter Gloviczki, Anthony J. Comerota, Michael C. Dalsing, Bo G. Eklof, David L. Gillespie, Monika L. Gloviczki, Joann M. Lohr, Robert B. McLafferty, Mark H. Meissner, M. Hassan Murad, Frank T. Padberg, Peter J. Pappas, Marc A. Passman Joseph D. Raffetto, Michael A. Vasquez, and Thomas W. Wakefield. “The care of patients with varicose veins and associated chronic venous diseases: Clinical practice guidelines of the Society for Vascular Surgery and the American Venous Forum.” J Vasc Surg . 2011;53:2S-48S. 5 5/30/2017 PREVALENCE OF CHRONIC VENOUS INSUFFICIENCY More than 30 million Americans suffer from varicose veins or a more serious form of venous disease called Chronic Venous Insufficiency (CVI). 1 Of the over 30 million Americans affected: Q Only 1.9 million seek treatment CVI Prevalence 1,2* annually. 1,2 30,000,000+ Q The vast majority remain undiagnosed and untreated. Seek Treatment *2 1,900,000 Treated 447,000 2 *Statistics based on individuals over the age of 40 1 Gloviczki P, et al. The care of patients with varicose veins and associated chronic diseases: clinical practice guidelines of the Society for Vascular Surgery and the American Venous Forum. JVS; May 2011. 2 Lee, A. US markets for varicose vein treatment devices 2011. Millennium Research Group, Inc. (A Decision Resource, Inc. Company), www.mrg.net, May 2011. 1 1 DISABILITY • Loss of productivity and working days • Financial burden of venous complications to patients and society (1) • Decreased quality of life (QOL) • Early retirement. (2) 1. Bergan JJ, Schmid-Schönbein GW, Smith PD, et al. Chronic venous disease. N Engl J Med. 2006; 355: 488–498. 2) Kaplan RM, Criqui MH, Denenberg JO, Bergan J, Fronek A. “Quality of life in patients with chronic venous disease: San Diego population study.” J Vasc Surg 2003;37:1047-53. 6 5/30/2017 DISABILITY • Chronic venous ulcerations result in the loss of 2 million workdays and cost the US healthcare system an estimated $3 billion for managing this chronic condition. (1,2) • The physical impairment observed with venous ulceration (C5 and C6) has been shown to be similar to that observed with congestive heart failure and chronic lung disease. (3) 1. Gloviczki P, Comerota AJ, Dalsing MC, et al; for the Society for Vascular Surgery; American Venous Forum. The care of patients with varicose veins and associated chronic venous diseases: clinical practice guidelines of the Society for Vascular Surgery and the American Venous Forum. J Vasc Surg. 2011; 53 (5 suppl): 2S–48S 2. McGuckin M, Waterman R, Brooks J, et al. Validation of venous leg ulcer guidelines in the United States and United Kingdom. Am J Surg. 2002; 183: 132– 1373. 3. Carradice D, Mazari FA, Samuel N, et al. Modelling the effect of venous disease on quality of life. Br J Surg. 2011; 98: 1089–1098. IMPORTANT STATISTICS ABOUT CHRONIC VENOUS INSUFFICIENCY Q Affects all age groups and is ten times more prevalent then PAD (1) Q Between 20-30% (30 million) people in the US have chronic venous disease (4), Q Only 1.9 million seek treatment (4) Q At least 20,556 patients receive a new diagnosis of venous ulcers each year 4 Q Direct cost of CVI in the US is estimated to be between $150 million and $3 billion per year (2) Q Indirect costs include 2 million lost workdays, decreased Quality of Life and early retirement ( 5) 1 Gordon P, Treat-Jacobson D, Sossoman L.B. Society for Vascular Nursing Position Statement on Inclusion of Vascular Disease into Nursing Education. Soc for Vascular Nursing. 2012;Sept:10. 2 Heller J. Treatment of chronic venous insufficiency. Supplement to Endovascular Today. 2011;Oct:12-15. 3 Weiss R, Venous Insufficiency. Medscape. November 21, 2012. 4 Gloviczki P, Comerota A.J, Dalsing M.C et al. The care of patients with varicose veins and associated chronic venous diseases: Clinical practice guidelines of the Society for Vascular Surgery and the American Venous Forum. J Vasc Surg. 2011;53(suppl):2S-48S. 5. Carradice D, Mazari FA, Samuel N, et al. Modelling the effect of venous disease on quality of life. Br J Surg. 2011; 98: 1089–1098. 1 4 7 5/30/2017 HISTORICAL EXPERIENCE ANCIENT GREECE Lysimachides , son of Lysimachos, from Acharnai. 4th century B.C. National Archeological Museum, Athens Greece 8 5/30/2017 EARLY AMERICAN MEDICINE www.givingblood.org MODERN ERA MEDICINE www.venacure-evlt.com 9 5/30/2017 CONTEMPORY TREATMENTS www.fallgeneralsurgery.com OPPORTUNITY 10 5/30/2017 THE VENOUS SPECTRUM • Lower extremity • Upper extremity • Abdominal • Thoracic THE VENOUS SPECTRUM • Spider veins • Reticular veins • Varicose Veins • Perforating veins • Deep veins • Central veins 11 5/30/2017 SUPERFICIAL VARICOSE VEINS • They’re ALL varicose veins • Legs • Subcutaneous varicose veins • Reticular varicose veins • Spider varicose vein • Arms • Rare • See deep venous disease EXTREMITY DEEP VENOUS DISEASE • Lower • Upper • Obstruction / Phlebitis • Obstruction / Phlebitis • Deep Venous Thrombosis (DVT) • Deep Venous Thrombosis (DVT) • Insufficiency / “Reflux” • Insufficiency (rare) • Perforating veins • Tibial veins • Popliteal vein • “Femoral vein” (previously “Superficial femoral vein”) • Common femoral vein 12 5/30/2017 EXTREMITY SUPERFICIAL VENOUS DISEASE • Lower • Upper • Obstruction / Phlebitis • Obstruction / Phlebitis • Superficial thrombophlebitis (SVT) • Insufficiency (rare) • Insufficiency / “Reflux” • Great Saphenous Vein (GSV) • Lesser Saphenous Vein (LSV) • Intersaphenous Vein of Giacomini • Superficial varicosities 13 5/30/2017 ORDER OF EVENTS: FRIDAY, 12:00 – 5:30PM • Overview • Robert Vorhies, MD • Anatomy and Physiology • John Waites, MD • Ultrasound Evaluations • Brent Wilkinson, RDMS • Conservative therapies • Julie Highfill, PA-C • Laura Ross, PA-C • Lymphedema • Jan Weiss, PT, DHS, CLT-LANA 14 5/30/2017 ORDER OF EVENTS: SATURDAY, 7:30AM – 1:00PM • Deep vein interventions • Randy Mullins, MD • Venous stasis and ulcers • John Waites, MD • Pelvic congestion • Randy Mullins, MD • Varicose vein procedures • Zak Schmittling, MD • Mechanico-Chemical Ablation • Robert Vorhies, MD REFERENCES • Peter Gloviczki, Anthony J. Comerota, Michael C. Dalsing, Bo G. Eklof, David L. Gillespie, Monika L. Gloviczki, Joann M. Lohr, Robert B. McLafferty, Mark H. Meissner, M. Hassan Murad, Frank T. Padberg, Peter J. Pappas, Marc A. Passman Joseph D. Raffetto, Michael A. Vasquez, and Thomas W. Wakefield. “The care of patients with varicose veins and associated chronic venous diseases: Clinical practice guidelines of the Society for Vascular Surgery and the American Venous Forum.” J Vasc Surg . 2011;53:2S-48S. • Lee, A. US markets for varicose vein treatment devices 2011. Millennium Research Group, Inc. (A Decision Resource, Inc. Company), www.mrg.net, May 2011. • Wikipedia Population lists of the United States • .venacure-evlt.com • .givingblood.org • fallgeneralsurgery.com • Kaplan RM, Criqui MH, Denenberg JO, Bergan J, Fronek A. “Quality of life in patients with chronic venous disease: San Diego population study.” J Vasc Surg 2003;37:1047-53 • Mallick R, Raju A, Campbell C, et al.
Load more

Recommended publications
  • Byoung Chan Kang, MD, Da Jeong Nam, MD*, Eun Kyoung Ahn, MD*, Duck Mi Yoon, MD, and Joung Goo Cho, MD*
    Korean J Pain 2013 July; Vol. 26, No. 3: 299-302 pISSN 2005-9159 eISSN 2093-0569 http://dx.doi.org/10.3344/kjp.2013.26.3.299 |Case Report| Secondary Erythromelalgia - A Case Report - Department of Anesthesiology and Pain Medicine, Yonsei University College of Medicine, Seoul, *National Health Insurance Service Ilsan Hospital, Goyang, Korea Byoung Chan Kang, MD, Da Jeong Nam, MD*, Eun Kyoung Ahn, MD*, Duck Mi Yoon, MD, and Joung Goo Cho, MD* Erythromelalgia is a rare neurovascular pain syndrome characterized by a triad of redness, increased temperature, and burning pain primarily in the extremities. Erythromelalgia can present as a primary or secondary form, and secondary erythromelalgia associated with a myeloproliferative disease such as essential thrombocythemia often responds dramatically to aspirin therapy, as in the present case. Herein, we describe a typical case of a 48-year-old woman with secondary erythromelalgia linked to essential thrombocythemia in the unilateral hand. As this case demonstrates, detecting and visualizing the hyperthermal area through infrared thermography of an erythromelalgic patient can assist in diagnosing the patient, assessing the therapeutic results, and understanding the disease course of erythromelalgia. (Korean J Pain 2013; 26: 299-302) Key Words: aspirin, erythromelalgia, infrared thermography, neuropathic pain. Erythromelalgia is a rare clinical syndrome charac- Adults are more commonly involved than children and are terized by a triad of redness, increased temperature, and more likely to have the secondary form. Secondary eryth- burning pain primarily in the extremities. The term eryth- romelalgia is usually associated with myeloproliferative romelalgia, derived from the Greek words for redness and disorders such as essential thrombocythemia (ET) and pol- pain in the extremities, was coined in 1878 by Mitchell [1].
    [Show full text]
  • Hemorrhoids Information, Pictures, Treatments, and Cures by Rick Shacket DO, 1989 ©
    Hemorrhoids Information, Pictures, Treatments, and Cures By Rick Shacket DO, 1989 © Hemorrhoids are cushions of tissue and varicose veins located in and around the rectal area. When they become inflamed, hemorrhoids can itch, bleed, and cause pain. Unfortunately a hemorrhoidal condition only tends to get worse over the years. That is why safe, gentle, and effective treatment for hemorrhoids is recommended as soon as they occur. Hemorrhoids bother about 89% of all Americans at some time in their lives. Hemorrhoids caused Napoleon to sit side-saddle, sent President Jimmy Carter to the operating room, and benched baseball star George Brett during the 1980 World Series. Over two thirds of all healthy people reporting for physical examinations have hemorrhoids. For more information about Hemorrhoids visit the links below: • Pictures: Hemorrhoids and Anal Fissure • Stapled Hemorrhoidopexy (PPH Procedure) • What Are Hemorrhoids? • Harmonic Scalpel Hemorrhoid surgery • What Are the Symptoms of Hemorrhoids? • Laser Surgery for Hemorrhoids • How Common Are Hemorrhoids? • Atomizing Hemorrhoids • How Are Hemorrhoids Diagnosed? • Complications of Hemorrhoid Surgery • What Is the Treatment? • Knowing What to Ask Your Surgeon • How Are Hemorrhoids Prevented? • Allopathic Hemorrhoid Medications • Painless Treatment of Hemorrhoids • Herbal Hemorrhoid Medications • HAL-RAR Method Hemorrhoidectomy • Homeopathic Hemorrhoid Medications • Hemorrhoids Grades 1 to 4 • References • Surgical Classification of Hemorrhoids • Video References • Traditional Surgery for Hemorrhoids Pictures: Hemorrhoids and Anal Fissure Internal hemorrhoids occur higher up in the anal canal, out of sight. Bleeding is the most common symptom of internal hemorrhoids, and often the only one in mild cases. View hemorrhoid gallery for detailed photos. Hemorrhoids Information, Pictures, Treatments, and Cures Page 1 of 21 External hemorrhoids are visible-occurring out side the anus.
    [Show full text]
  • Portal Hypertensionand Its Radiological Investigation
    Postgrad Med J: first published as 10.1136/pgmj.39.451.299 on 1 May 1963. Downloaded from POSTGRAD. MED. J. (I963), 39, 299 PORTAL HYPERTENSION AND ITS RADIOLOGICAL INVESTIGATION J. H. MIDDLEMISS, M.D., F.F.R., D.M.R.D. F. G. M. Ross, M.B., B.Ch., B.A.O., F.F.R., D.M.R.D. From the Department of Radiodiagnosis, United Bristol Hospitals PORTAL hypertension is a condition in which there branch of the portal vein but may drain into the right is an blood in the branch. abnormally high pressure Small veins which are present on the serosal surface portal system of veins which eventually leads to of the liver and in the surrounding peritoneal folds splenomegaly and in chronic cases, to haematem- draining the diaphragm and stomach are known as esis and melaena. accessory portal veins. They may unite with the portal The circulation is in that it vein or enter the liver independently. portal unique The hepatic artery arises normally from the coeliac exists between two sets of capillaries, i.e. the axis but it may arise as a separate trunk from the aorta. capillaries of the spleen, pancreas, gall-bladder It runs upwards and to the right and divides into a and most of the gastro-intestinal tract on the left and right branch before entering the liver at the one hand and the sinusoids of the liver on the porta hepatis. The venous return starts as small thin-walled branches other hand. The liver parallels the lungs in that in the centre of the lobules in the liver.
    [Show full text]
  • Reprint Of: Why Are Hemorrhoids Symptomatic? the Pathophysiology and Etiology of Hemorrhoids
    Seminars in Colon and Rectal Surgery 29 (2018) 160 166 À Contents lists available at ScienceDirect Seminars in Colon and Rectal Surgery journal homepage: www.elsevier.com/locate/yscrs Reprint of: Why are hemorrhoids symptomatic? the pathophysiology and etiology of hemorrhoids WilliamD1X X C. Cirocco, MD,D2X X FACS, FASCRS* Department of Surgery, University of Missouri Kansas City, Kansas City, Missouri. À ABSTRACT Hemorrhoids are a normal component of the anorectum and contribute to the mechanism of anal closure, thus providing fine adjustment of anal continence. There are numerous myths and legends associated with the disordered and diseased state of hemorrhoids. Fortunately, information obtained from modern technolo- gies including microscopic histopathology defined first the actual substance and makeup of hemorrhoids and was later combined with anorectal physiology to provide evidence establishing the underlying pathophysiol- ogy of this universal finding of the human anorectum. The sliding anal canal theory of Gass and Adams has held up and is further supported by other anatomic studies including the work of WHF Thomson, who popu- larized the term “cushions” to describe the complex intertwining of muscle, connective tissue, veins, arteries, and arteriovenous communications which constitute hemorrhoids. A loss of muscle mass in favor of connec- tive tissue over time helps explain the role of aging as a predisposing factor for symptomatic hemorrhoids. Other factors include the modern “rich” or low-residue diet leading to constipation and straining which con- tributes to prolapsing cushions. Pathologic studies also demonstrated arteriovenous communications explain- ing why hemorrhoid bleeding is typically bright red or arterial in nature as opposed to dark or venous bleeding.
    [Show full text]
  • Treatment Strategies for Patients with Lower Extremity Chronic Venous Disease (LECVD)
    Evidence-based Practice Center Systematic Review Protocol Project Title: Treatment Strategies for Patients with Lower Extremity Chronic Venous Disease (LECVD) Project ID: DVTT0515 Initial publication date if applicable: March 7, 2016 Amendment Date(s) if applicable: May 6th, 2016 (Amendments Details–see Section VII) I. Background for the Systematic Review Lower extremity chronic venous disease (LECVD) is a heterogeneous term that encompasses a variety of conditions that are typically classified based on the CEAP classification, which defines LECVD based on Clinical, Etiologic, Anatomic, and Pathophysiologic parameters. This review will focus on treatment strategies for patients with LECVD, which will be defined as patients who have had signs or symptoms of LE venous disease for at least 3 months. Patients with LECVD can be asymptomatic or symptomatic, and they can exhibit a myriad of signs including varicose veins, telangiectasias, LE edema, skin changes, and/or ulceration. The etiology of chronic venous disease includes venous dilation, venous reflux, (venous) valvular incompetence, mechanical compression (e.g., May-Thurner syndrome), and post-thrombotic syndrome. Because severity of disease and treatment are influenced by anatomic segment, LECVD is also categorized by anatomy (iliofemoral vs. infrainguinal veins) and type of veins (superficial veins, perforating veins, and deep veins). Finally, the pathophysiology of LECVD is designated typically as due to the presence of venous reflux, thrombosis, and/or obstruction. LECVD is common
    [Show full text]
  • A Case of Extensive Igg4-Related Disease Presenting As Massive Pleural Effusion, Mediastinal Mass, and Mesenteric Lymphadenopathy in a 16-Year-Old Male
    http://dx.doi.org/10.4046/trd.2015.78.4.396 CASE REPORT ISSN: 1738-3536(Print)/2005-6184(Online) • Tuberc Respir Dis 2015;78:396-400 A Case of Extensive IgG4-Related Disease Presenting as Massive Pleural Effusion, Mediastinal Mass, and Mesenteric Lymphadenopathy in a 16-Year-Old Male Eun Kyong Goag, M.D.1,2, Ji Eun Park, M.D.1,2, Eun Hye Lee, M.D.1,2, Young Mok Park, M.D.1,2, Chi Young Kim, M.D.1,2, Jung Mo Lee, M.D.1,2, Young Joo Kim, M.D.2, Young Sam Kim, M.D., Ph.D.1,2, Se Kyu Kim, M.D., Ph.D.1,2, Joon Chang, M.D., Ph.D.1,2, Moo Suk Park, M.D., Ph.D.1,2 and Kyung Soo Chung, M.D.1,2 1Division of Pulmonology, 2Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea IgG4-related disease is an immune-mediated fibro-inflammatory disease, characterized by lymphoplasmacytic infiltration composed of IgG4-positive plasma cells of various organs with elevated circulating levels of IgG4. This disease is now reported with increasing frequency and usually affects middle-aged men. Massive pleural effusion in children is an uncommon feature in IgG4-related disease. Here, we report a case of a 16-year-old male patient with extensive IgG4- related disease presenting with massive pleural effusion, mediastinal mass, and mesenteric lymphadenopathy. Keywords: Pleural Effusion; Mediastinum Introduction with increasing frequency1. IgG4-related disease can involve almost any organ, including the skin, pericardium, thyroid, IgG4-related disease is a recently recognized immune-me- prostate, breast, aorta, meninges, lymph nodes, lungs, kidneys, diated systemic condition that characteristically presents with periorbital tissues, salivary glands, biliary tract, and pancreas2.
    [Show full text]
  • Phlebitis and Thrombophlebitis
    EDITORIAL Phlebitis and thrombophlebitis Christopher Rockman* Rockman C. Phlebitis and thrombophlebitis. J Phlebol Lymphol. 14(2):13 you are not better during a week or two or if it gets any worse, get re- INTRODUCTION evaluated to form sure you do not have a more serious condition. There is usually a slow onset of a young red area along the superficial veins on the hlebitis (fle-BYE-tis) means inflammation of a vein. Thrombophlebitis is skin. A long, thin red area could also be seen because the inflammation P follows a superficial vein. This area may feel hard, warm, and tender. thanks to one or more blood clots during a vein that cause inflammation. Thrombophlebitis usually occurs in leg veins, but it's going to occur in an arm or In most cases, superficial thrombophlebitis goes away on its own after a couple of other parts of the body. weeks. If needed, we can encourage healing with: Oral or topical nonsteroidal anti- inflammatory drugs (NSAIDs) Exercise. Mechanical phlebitis occurs where the movement of a far off object (cannula) within a vein causes friction and subsequent venous When phlebitis is superficial, a blood clot arises in the superficial veins, which inflammation. are the veins that are just under the surface of the skin. This type of disorder is common and is typically a benign and self-limiting disease. DVT, on the other hand, Chemical phlebitis is caused by the drug or fluid being infused through the is a blood clot that develops in a vein deep in the body. cannula and Infective phlebitis.
    [Show full text]
  • Cautions in Adjunct Therapies
    THERAPEUTIC CONTRAINDICATIONS & CAUTIONS MARY ANNE MATTA TUINA Avoid in active skin lesions, open wounds, factures, infections, acute trauma. Consult physician after surgery or during cancer treatment. BLOOD LETTING Indications à tonsillitis, neurodermatitis, allergic dermatitis, acute sprain, heatstroke, abscesses, febrile diseases, headache, rhinitis, acute conjunctivitis or keratitis, numbness of the fingers or toes, erysipelas, eczema, lymphangitis, phlebitis, hemorrhoids, coma, wind-stroke Contraindications à active lesions, bleeding disorders, hemorrhagic diseases, vascular tumors, pregnant or recently delivered women, or weak, anemic and hypotensive patients, patients taking anticoagulants, convulsions, NSAIDS and other supplements that thin the blood (ex: Vitamin E & fish oil). Moxa the site if bleeding continues. Caution à wear gloves & PPE, prep the skin, use single sterile needles/lancets and dispose immediately, use glass or disposable cups if wet cupping. If using a pen-like device for lancing, do not reuse on subsequent patients even when changing out the lancet. Use a new pen for each new patient. CUTANEOUS NEEDLE 2 Types: Plum blossom or rolling drum. Indications à hypertension, headache, myopia, dysmenorrhea, intercostal neuralgia, neurasthenia, GI disorders, dermatitis. Contraindications à ulcerations, traumatic injury, acute infectious diseases, acute abdominal disorders. Cautions: Always go above-to-below or medial-to-lateral. Stop when skin gets red. Do not puncture the skin. Hold hammer 1-2 inches above skin surface
    [Show full text]
  • Peripheral Arteriovascular Disease Shownotes
    CrackCast Show Notes – Peripheral Arteriovascular Disease – June 2017 www.canadiem.org/crackcast Chapter 87 – Peripheral Arteriovascular Disease Episode Overview: 1. What is an atheroma and how is it formed? 2. What are the classic symptoms of arterial insufficiency? 3. Provide a differential diagnosis for chronic arterial insufficiency. 4. What is blue toe syndrome? What is its significance? 5. Differentiate between thrombotic and embolic limb ischemia based on clinical features. 6. What is the management of an acutely ischemic limb? 7. List three disorders characterized by abnormal vasomotor response. 8. Describe Raynaud's disease and how it’s treated? 9. What is the most common site for an arterial aneurysm in the leg? 10. List four potential sites for upper extremity aneurysms, and their associated underlying causes. 11. Name three types of visceral aneurysms and their associated conditions. 12. List 6 differential diagnosis of an occluded indwelling catheter and describe the management of a suspected line infection. 13. What are the two types of arteriovenous (AV) fistulae used for dialysis? 14. How do you access an AV fistula? 15. List 5 complications of dialysis fistulas and treatment. 16. List the 3 types of thoracic outlet syndrome. What are the typical symptoms of thoracic outlet syndrome? What is a simple bedside test for this condition? 17. List 4 anatomic abnormalities associated with thoracic outlet syndrome. Wisecracks: 1. Describe Buerger’s sign and the ankle brachial index. 2. List the clinical criteria for Buerger’s Disease (5). 3. What is Leriche's syndrome? 4. List 4 types of infectious aneurysms. 5. Differentiate between arterial insufficiency ulcers and venous stasis ulcers.
    [Show full text]
  • Neonatal Pleural Effusions in a Level III Neonatal Intensive Care Unit
    www.jpnim.com Open Access eISSN: 2281-0692 Journal of Pediatric and Neonatal Individualized Medicine 2015;4(1):e040123 doi: 10.7363/040123 Received: 2015 Feb 21; revised: 2015 Apr 09; accepted: 2015 Apr 13; published online: 2015 Apr 28 Original article Neonatal pleural effusions in a Level III Neonatal Intensive Care Unit Mariana Barbosa1, Gustavo Rocha2, Filipa Flôr-de-Lima2, Hercília Guimarães1,2 1Faculty of Medicine of Porto University, Porto, Portugal 2Department of Pediatrics, Division of Neonatology, Hospital de São João, Porto, Portugal Abstract Pleural effusions are rare in the newborn. Still, being familiar with this condition is relevant given its association with a wide range of disorders. Only two large series of cases on this matter have been published, with no solid conclusions established. The aim of this study is to determine the etiology, management and prognosis of pleural effusions in a population of high-risk neonates. The authors performed a retrospective study in the Neonatal Intensive Care Unit of “Hospital de São João”, Porto (Portugal), between 1997 and 2014, of all newborns with the diagnosis of pleural effusion, chylothorax, hemothorax, empyema, fetal hydrops or leakage of total parenteral nutrition (TPN). Eighty-two newborns were included, 48 males and 34 females. Pleural effusions were congenital in 19 (23.2%) newborns and acquired in 63 (76.8%). Fetal hydrops was the most frequent cause (15 cases, 78.9%) of congenital effusions while postoperative after intrathoracic surgery was the most common cause (39 cases, 61.9%) of acquired effusions, followed by leakage of TPN (13 cases, 20.6%). Chylothorax was the most common type of effusion (41.5% of cases).
    [Show full text]
  • Chylous Ascytes Secondary to Acute Pancreatitis: a Case Report and Review of Literature J
    Nutr Hosp. 2012;27(1):314-318 ISSN 0212-1611 • CODEN NUHOEQ S.V.R. 318 Caso clínico Chylous ascytes secondary to acute pancreatitis: a case report and review of literature J. M. Gómez-Martín1, E. Martínez-Molina2, A. Sanjuanbenito2, E. Martín-Illana3, F. Arrieta1, J. A. Balsa1, I. Zamarrón1, C. Vázquez1,4 and J. I. Botella-Carretero1,4 1Unit of Clinical Nutrition and Dietetics. Department of Endocrinology and Nutrition. 2Department of General Surgery. 3Department of Radiology. 4CIBER de Fisiopatología de la Obesidad y Nutrición (CIBEROBN). Hospital Universitario Ramón y Cajal. IRYCIS. Madrid. España. Abstract ASCITIS QUILOSA SECUNDARIA A PANCREATITIS: CASO CLÍNICO Y REVISIÓN Chylous ascites is an uncommon finding which is due DE LA BIBLIOGRAFÍA to the presence of thoracic or intestinal lymph in the abdominal cavity. It is usually caused by a chronic dis- Resumen ruption of the lymphatic system. The present report is one of the rare cases in the literature of chylous ascites sec- La ascitis quilosa es un hallazgo infrecuente producido ondary to idiopathic acute pancreatitis, which showed a por la presencia de linfa de origen torácico o intestinal en complete resolution with a combination of low fat enteral la cavidad abdominal. Normalmente es producido por la nutrition with MCT and somatostatin analogs. disfunción crónica del sistema linfático. El caso que pre- (Nutr Hosp. 2011;27:314-318) sentamos es uno de los pocos casos descritos en la litera- tura de ascitis quilosa secundaria a una pancreatitis DOI:10.3305/nh.2012.27.1.5481 aguda idiopática, que se resolvió completamente con una Key words: Chylous ascites.
    [Show full text]
  • Prevention and Treatment of Phlebitis Secondary to the Insertion of a Peripheral Venous Catheter: a Scoping Review from a Nursing Perspective
    healthcare Review Prevention and Treatment of Phlebitis Secondary to the Insertion of a Peripheral Venous Catheter: A Scoping Review from a Nursing Perspective Aitana Guanche-Sicilia 1,†, María Begoña Sánchez-Gómez 2,†, María Elisa Castro-Peraza 2 , José Ángel Rodríguez-Gómez 3, Juan Gómez-Salgado 4,5,* and Gonzalo Duarte-Clíments 2 1 University Hospital Nuestra Señora de Candelaria, Canary Islands Health Service, 38010 Tenerife, Spain; [email protected] 2 University School of Nursing Nuestra Señora de Candelaria, University of La Laguna, 38001 Tenerife, Spain; [email protected] (M.B.S.-G.); [email protected] (M.E.C.-P.); [email protected] (G.D.-C.) 3 Chair of Nursing, Faculty of Health Sciences, University of La Laguna, 38001 Tenerife, Spain; [email protected] 4 Department of Sociology, Social Work and Public Health. Faculty of Labour Sciences, University of Huelva, 21007 Huelva, Spain 5 Safety and Health Postgraduate Programme, Universidad Espíritu Santo, 092301 Guayaquil, Ecuador * Correspondence: [email protected]; Tel.: +34-959219700 † These authors are co-first authors, as they contributed equally to this work. Citation: Guanche-Sicilia, A.; Abstract: The objective of this work was to identify available evidence on nursing interventions for Sánchez-Gómez, M.B.; Castro-Peraza, the prevention and treatment of phlebitis secondary to the insertion of a peripheral venous catheter. M.E.; Rodríguez-Gómez, J.Á.; Gómez- For this, a scoping systematic review was carried out following the guidelines in the PRISMA Salgado, J.; Duarte-Clíments, G. declaration of documents published between January 2015 and December 2020. The search took Prevention and Treatment of Phlebitis place between December 2020 and January 2021.
    [Show full text]